title: Cyclosporin A inhibits DNA synthesis by epidermal Langerhans cells.
abstract: Cyclosporin A, a potent immunosuppressive drug currently used in organ transplant recipients, has been shown to exert in vitro a direct antiproliferative effect on a number of cell types present in the skin, including keratinocytes, fibroblasts, and endothelial cells. Although in vitro studies suggest that cyclosporin A may interfere with the functional capacities of epidermal Langerhans cells, there is no evidence that the treatment influences the distribution or number of Langerhans cells in vivo. We used a model of normal human skin graft to "nude" mice, which is free of the human systemic control mechanisms, for studies on the DNA synthesis of human Langerhans cells under the influence of cyclosporin A. The grafted animals were given daily subcutaneous (50 mg/kg) or intraperitoneal (5, 12.5, and 25 mg/kg) drug injections during three weeks, which resulted in mean blood levels comparable to those observed in treated patients with organ transplants or psoriasis, respectively. BrdU administered during the last week of the experiment was incorporated by all cells synthesizing DNA, including those passing through S-phase. Langerhans cells were detected on deparaffinized or frozen tissue sections of xenografts with anti-CD1a and anti-HLA DR monoclonal antibodies, and the number of BrdU-positive cells was determined by double labeling. Our results indicate that the Langerhans cell DNA synthesis is impaired by therapeutic levels of cyclosporin A.
authors.affiliation: Department of Dermatology, INSERM U.209, CNRS, Hôpital E. Herriot, Lyon, France.
authors.forename: M
authors.initials: M
authors.lastname: Haftek
authors.forename: A
authors.initials: A
authors.lastname: Urabe
authors.forename: J
authors.initials: J
authors.lastname: Kanitakis
authors.forename: N
authors.initials: N
authors.lastname: Dusserre
authors.forename: J
authors.initials: J
authors.lastname: Thivolet
mesh_terms: D000328:Adult; D000818:Animals; D015703:Antigens, CD / Q000276:immunology; D018949:Antigens, CD1; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002452:Cell Count; D016572:Cyclosporine / Q000494:pharmacology*; D004247:DNA / Q000096:biosynthesis*; D004261:DNA Replication / Q000187:drug effects; D005260:Female; D005455:Fluorescent Antibody Technique; D006684:HLA-DR Antigens / Q000276:immunology; D006801:Humans; D007801:Langerhans Cells / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D008819:Mice, Nude; D012867:Skin / Q000166:cytology / Q000187:drug effects*; D016038:Skin Transplantation / Q000276:immunology; D014183:Transplantation, Heterologous
chemical_list: D015703:Antigens, CD; D018949:Antigens, CD1; D006684:HLA-DR Antigens; D016572:Cyclosporine; D004247:DNA; D001973:Bromodeoxyuridine